BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 22596319)

  • 1. Maintaining differentiated cellular identity.
    Holmberg J; Perlmann T
    Nat Rev Genet; 2012 May; 13(6):429-39. PubMed ID: 22596319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concise review: Oct4 and more: the reprogramming expressway.
    Sterneckert J; Höing S; Schöler HR
    Stem Cells; 2012 Jan; 30(1):15-21. PubMed ID: 22009686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-based system in stem cell reprogramming; differentiation/dedifferentiation.
    Pourrajab F; Babaei Zarch M; BaghiYazdi M; Hekmatimoghaddam S; Zare-Khormizi MR
    Int J Biochem Cell Biol; 2014 Oct; 55():318-28. PubMed ID: 25150833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues.
    Hanna JH; Saha K; Jaenisch R
    Cell; 2010 Nov; 143(4):508-25. PubMed ID: 21074044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards understanding transcriptional networks in cellular reprogramming.
    Firas J; Polo JM
    Curr Opin Genet Dev; 2017 Oct; 46():1-8. PubMed ID: 28646660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A model for genetic and epigenetic regulatory networks identifies rare pathways for transcription factor induced pluripotency.
    Artyomov MN; Meissner A; Chakraborty AK
    PLoS Comput Biol; 2010 May; 6(5):e1000785. PubMed ID: 20485562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial function in pluripotent stem cells and cellular reprogramming.
    Bukowiecki R; Adjaye J; Prigione A
    Gerontology; 2014; 60(2):174-82. PubMed ID: 24281332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reprogramming cell fates: insights from combinatorial approaches.
    Pereira CF; Lemischka IR; Moore K
    Ann N Y Acad Sci; 2012 Aug; 1266():7-17. PubMed ID: 22901251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High throughput sequencing identifies an imprinted gene, Grb10, associated with the pluripotency state in nuclear transfer embryonic stem cells.
    Li H; Gao S; Huang H; Liu W; Huang H; Liu X; Gao Y; Le R; Kou X; Zhao Y; Kou Z; Li J; Wang H; Zhang Y; Wang H; Cai T; Sun Q; Gao S; Han Z
    Oncotarget; 2017 Jul; 8(29):47344-47355. PubMed ID: 28476045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in understanding reprogramming to the induced pluripotent state.
    Plath K; Lowry WE
    Nat Rev Genet; 2011 Apr; 12(4):253-65. PubMed ID: 21415849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dedifferentiation, transdifferentiation and reprogramming: three routes to regeneration.
    Jopling C; Boue S; Izpisua Belmonte JC
    Nat Rev Mol Cell Biol; 2011 Feb; 12(2):79-89. PubMed ID: 21252997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concise review: Induced pluripotent stem cells versus embryonic stem cells: close enough or yet too far apart?
    Bilic J; Izpisua Belmonte JC
    Stem Cells; 2012 Jan; 30(1):33-41. PubMed ID: 22213481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linking incomplete reprogramming to the improved pluripotency of murine embryonal carcinoma cell-derived pluripotent stem cells.
    Chang G; Miao YL; Zhang Y; Liu S; Kou Z; Ding J; Chen DY; Sun QY; Gao S
    PLoS One; 2010 Apr; 5(4):e10320. PubMed ID: 20436676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generating autologous hematopoietic cells from human-induced pluripotent stem cells through ectopic expression of transcription factors.
    Hwang Y; Broxmeyer HE; Lee MR
    Curr Opin Hematol; 2017 Jul; 24(4):283-288. PubMed ID: 28383341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From skin to the treatment of diseases--the possibilities of iPS cell research in dermatology.
    Galach M; Utikal J
    Exp Dermatol; 2011 Jun; 20(6):523-8. PubMed ID: 21585557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromatin connections to pluripotency and cellular reprogramming.
    Orkin SH; Hochedlinger K
    Cell; 2011 Jun; 145(6):835-50. PubMed ID: 21663790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering cell fate: Spotlight on cell-activation and signaling-directed lineage conversion.
    Ebrahimi B
    Tissue Cell; 2016 Oct; 48(5):475-87. PubMed ID: 27514850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic Aberrations Are Not Specific to Transcription Factor-Mediated Reprogramming.
    Tiemann U; Wu G; Marthaler AG; Schöler HR; Tapia N
    Stem Cell Reports; 2016 Jan; 6(1):35-43. PubMed ID: 26711876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic Control of Reprogramming and Transdifferentiation by Histone Modifications.
    Qin H; Zhao A; Zhang C; Fu X
    Stem Cell Rev Rep; 2016 Dec; 12(6):708-720. PubMed ID: 27623868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromatin states in pluripotent, differentiated, and reprogrammed cells.
    Fisher CL; Fisher AG
    Curr Opin Genet Dev; 2011 Apr; 21(2):140-6. PubMed ID: 21316216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.